rs10994359

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.96+152837A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0854 in 152,186 control chromosomes in the GnomAD database, including 1,131 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.085 ( 1131 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00400

Publications

26 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.63+110116A>G intron_variant Intron 1 of 43 NP_001191333.1
ANK3NM_001204403.2 linkc.96+152837A>G intron_variant Intron 2 of 43 NP_001191332.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.96+152837A>G intron_variant Intron 2 of 43 1 ENSP00000362933.2
ANK3ENST00000503366.6 linkc.63+110116A>G intron_variant Intron 1 of 43 2 ENSP00000425236.1
ANK3ENST00000622427.4 linkn.63+110116A>G intron_variant Intron 1 of 32 2 ENSP00000483244.1

Frequencies

GnomAD3 genomes
AF:
0.0854
AC:
12986
AN:
152066
Hom.:
1126
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0163
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.202
Gnomad ASJ
AF:
0.0441
Gnomad EAS
AF:
0.323
Gnomad SAS
AF:
0.164
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.0414
Gnomad NFE
AF:
0.0654
Gnomad OTH
AF:
0.0746
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0854
AC:
12994
AN:
152186
Hom.:
1131
Cov.:
32
AF XY:
0.0956
AC XY:
7109
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0163
AC:
677
AN:
41574
American (AMR)
AF:
0.203
AC:
3100
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0441
AC:
153
AN:
3472
East Asian (EAS)
AF:
0.322
AC:
1656
AN:
5140
South Asian (SAS)
AF:
0.162
AC:
779
AN:
4822
European-Finnish (FIN)
AF:
0.189
AC:
2003
AN:
10584
Middle Eastern (MID)
AF:
0.0411
AC:
12
AN:
292
European-Non Finnish (NFE)
AF:
0.0654
AC:
4449
AN:
68012
Other (OTH)
AF:
0.0766
AC:
162
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
553
1106
1659
2212
2765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0774
Hom.:
1441
Bravo
AF:
0.0861
Asia WGS
AF:
0.246
AC:
852
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.4
DANN
Benign
0.82
PhyloP100
-0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10994359; hg19: chr10-62222107; API